Association of Genetic Variants, Such as the μ-Opioid Receptor 1 (OPRM1) rs1799971 and Catechol-O-Methyltransferase (COMT) rs4680, with Phenotypic Expression of Fibromyalgia
Authors:
Open Access
- 13 May 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (5) , 1183
Abstract
Background/Objectives: Genetic variants, such as the µ-opioid receptor 1 (OPRM1) rs1799971 and the catechol-O-methyltransferase (COMT) rs4680, have been considered among the potential causes in the development of some chronic pain conditions. In this regard, there are controversial results regarding their roles in fibromyalgia (FM). We aimed to investigate whether the OPRM1 rs1799971 and COMT rs4680 polymorphisms are associated with the development of or susceptibility to FM, as well as their potential association with syndrome characteristic variables, in a sample of the Spanish population with and without FM. Methods: The present study analysed COMT Val158Met and OPRM1 Asn40Asp genetic variants in 311 FM patients (301 women and 10 men) and 135 non-FM participants (120 women and 15 men). In addition to clinical variables, widespread pain index (WPI), symptom severity scale (SSS) (fatigue, rest quality, and cognitive symptoms), pain, stress episodes, and Borg scale were collected. Results: The main results indicate that women carrying the Val/Val genotype (i.e., high COMT activity) exhibited significantly lower levels of fatigue, cognitive impairment, and total SSS than heterozygote carriers. In addition, Met allele carriers (i.e., lower COMT activity) showed higher probabilities of suffering a stress episode and higher levels of exertion during daily activities. Conclusions: The present research suggests a link between dopaminergic dysfunction and exacerbated, frequently described symptoms in female FM patients. Although further research with wider genetic variants and recruited patients is needed, these results point out the necessity of considering gender as a separate category in chronic pain studies.Keywords
Funding Information
- Cátedra Conocimiento e Innovación Caja Rural de Soria
This publication has 57 references indexed in Scilit:
- Polymorphisms of the μ‐opioid receptor gene influence cerebral pain processing in fibromyalgiaEuropean journal of pain, 2020
- Comorbid fibromyalgia: A qualitative review of prevalence and importanceEuropean journal of pain, 2018
- Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysisRheumatology International, 2014
- FibromyalgiaJAMA, 2014
- Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgiaRheumatology International, 2014
- Effects of Genetic Variations in the Dopaminergic System on Fatigue in Humans: Gender AspectsBulletin of Experimental Biology and Medicine, 2010
- The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom SeverityArthritis Care & Research, 2010
- Pathophysiology of FibromyalgiaThe American Journal of Medicine, 2009
- Cancer-related fatigue: Links with inflammation in cancer patients and survivorsBrain, Behavior, and Immunity, 2007
- Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scalePain, 1983